Across TCGA pan-cancer cohorts, VN1R104P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of VN1R104P’s most consistent transcriptional readouts.
The strongest signal is observed in esophageal carcinoma (ESCA), where VN1R104P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types VN1R104P is over-expressed in tumor.
ESCA are the cancer types where VN1R104P tumor–normal differential expression is most reproducible.